Rockefeller Capital Management
CAI

Rockefeller Capital Management’s Caris Life Sciences CAI Stock Holding History

Rockefeller Capital Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.7K Buy
995
+860
+637% +$15.4K ﹤0.01% 3772
2026
Q1 		$2.41K Buy
135
+100
+286% +$2.19K ﹤0.01% 4380
2025
Q4 		$944 Buy
+35
New +$986 ﹤0.01% 4454

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rockefeller Capital Management's CAI Position: Q2 2026 in Review

Rockefeller Capital Management increased its Caris Life Sciences (CAI) stake by 637% in Q2 2026, buying an estimated $15.4K and bringing the position to 995 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3772.

Rockefeller Capital Management first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Rockefeller Capital Management held 995 shares of Caris Life Sciences worth $17.7K as of Q2 2026.
  • Rockefeller Capital Management bought 860 Caris Life Sciences shares in Q2 2026, an estimated $15.4K.
  • Caris Life Sciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3772 holding.
  • Rockefeller Capital Management first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.